4-(4-(dimethylamino)phenyl)nicotinonitrile | 1428419-75-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 4-(4-(dimethylamino)phenyl)nicotinonitrile
• 英文别名: 4-[4-(Dimethylamino)phenyl]pyridine-3-carbonitrile；4-[4-(dimethylamino)phenyl]pyridine-3-carbonitrile
• CAS: 1428419-75-3
• 化学式: C₁₄H₁₃N₃
• 分子量: 223.277
• InChiKey: HLNLWWJSQUEJAH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  17
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  39.9
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  3-氰基吡啶 、 4-(N,N-dimethylamino)phenylmagnesium bromide lithium chloride complex 在 三氟化硼乙醚 、 四氯苯醌 作用下， 以 四氢呋喃 为溶剂， 反应 14.25h， 以99%的产率得到4-(4-(dimethylamino)phenyl)nicotinonitrile
  参考文献：
  名称：

  使用格氏试剂或有机锌试剂对功能化吡啶进行无过渡金属 BF3 介导的区域选择性直接烷基化和芳基化

  摘要：

  各种吡啶与烷基和芳基的正式区域选择性交叉偶联可以通过 BF3·OEt2 介导的格氏试剂或有机锌试剂加成到带有各种取代基（氯、溴、氰基、乙烯基、苯基、碳乙氧基、硝基、等），然后是由氯苯醌介导的氧化芳构化。良好的区域选择性和广泛的官能团耐受性使该方法非常适用于制备多官能吡啶。在这些偶联反应中不需要过渡金属催化剂。

  DOI：

  10.1021/ja401146v

文献信息

• [EN] AMYLOID TARGETING AGENTS AND METHODS OF USING THE SAME<br/>[FR] AGENTS CIBLANT LES AMYLOÏDES ET PROCÉDÉS DE LEUR UTILISATION
  申请人：AMYDIS DIAGNOSTICS

  公开号：WO2015143185A1

  公开（公告）日：2015-09-24

  Provided herein is the design and synthesis of novel molecular rotor fluorophores useful for detection of amyloid or amyloid like proteins. The fluorophores are designed to exhibit enhanced fluorescence emission upon associating with amyloid or amyloid like proteins as compared to unbound compound. Also disclosed herein are the methods for treating of diseases associated with an amyloid or amyloid like proteins.

  本文提供了用于检测淀粉样蛋白或类淀粉样蛋白的新型分子转子荧光团的设计和合成。这些荧光团被设计为与淀粉样蛋白或类淀粉样蛋白结合时，与未结合化合物相比表现出增强的荧光发射。本文还披露了用于治疗与淀粉样蛋白或类淀粉样蛋白相关疾病的方法。
• [EN] METHODS OF DETECTING NEUROLOGICAL DISORDERS VIA BINDING TO PHOSPHORYLATED TAU PROTEIN<br/>[FR] MÉTHODES DE DÉTECTION DE TROUBLES NEUROLOGIQUES PAR LIAISON À UNE PROTÉINE TAU PHOSPHORYLÉE
  申请人：SARRAF STELLA

  公开号：WO2021055639A1

  公开（公告）日：2021-03-25

  Provided herein are methods and compositions for determining whether a patient suffers from a neurological disease or disorder is provided, comprising detecting the presence of a phosphorylated tau protein in a tissue of the patient, wherein the detecting comprises contacting the phosphorylated tau protein with a compound described herein.

  本文提供了一种确定患者是否患有神经系统疾病或紊乱的方法和组合物，包括检测患者组织中磷酸化tau蛋白的存在，其中检测包括将磷酸化tau蛋白与本文描述的化合物接触。
• COMPOSITIONS AND METHODS FOR DETECTION OF TRAUMATIC BRAIN INJURY
  申请人：Amydis, Inc.

  公开号：US20210369873A1

  公开（公告）日：2021-12-02

  The present disclosure relates generally to compositions and methods for determining whether a patient suffers from a traumatic brain injury (TBI) by detecting the presence of an amyloid beta protein in an eye of the patient. Also provided are compositions and methods for preparing a patient for diagnosis and treatment of traumatic brain injury (TB).

  本公开涉及一般用于确定患者是否患有创伤性脑损伤（TBI）的组合物和方法，通过检测患者眼睛中淀粉样蛋白的存在。还提供了用于为创伤性脑损伤（TBI）的诊断和治疗准备患者的组合物和方法。
• Amyloid targeting agents and methods of using the same
  申请人：Amydis Diagnostics, Inc.

  公开号：US10005745B2

  公开（公告）日：2018-06-26

  Provided herein is the design and synthesis of novel molecular rotor fluorophores useful for detection of amyloid or amyloid like proteins. The fluorophores are designed to exhibit enhanced fluorescence emission upon associating with amyloid or amyloid like proteins as compared to unbound compound. Also disclosed herein are the methods for treating of diseases associated with an amyloid or amyloid like proteins.

  本文提供了可用于检测淀粉样蛋白或类似淀粉样蛋白的新型分子转子荧光团的设计与合成。与未结合的化合物相比，这些荧光团在与淀粉样蛋白或类似淀粉样蛋白结合时会表现出更强的荧光发射。本文还公开了治疗与淀粉样蛋白或类似淀粉样蛋白相关疾病的方法。
• AMYLOID TARGETING AGENTS AND METHODS OF USING THE SAME
  申请人：AMYDIS DIAGNOSTICS

  公开号：US20160326126A1

  公开（公告）日：2016-11-10

  Provided herein is the design and synthesis of novel molecular rotor fluorophores useful for detection of amyloid or amyloid like proteins. The fluorophores are designed to exhibit enhanced fluorescence emission upon associating with amyloid or amyloid like proteins as compared to unbound compound. Also disclosed herein are the methods for treating of diseases associated with an amyloid or amyloid like proteins.